e-learning
resources
Monograph
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Stem cells and lung cancer
Kyren A. Lazarus, Adam Pennycuick, Robert E. Hynds, Sam M. Janes
Source:
Eur Respir Monogr 2021; 91: 340-352
Journal Issue:
Lung Stem Cells in Development, Health and Disease
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kyren A. Lazarus, Adam Pennycuick, Robert E. Hynds, Sam M. Janes. Stem cells and lung cancer. Eur Respir Monogr 2021; 91: 340-352
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Lung stem cells and lung cancer
Source: ERS Lung Science Conference 2017
Year: 2017
Stem cells and lung cancer treatment: any hope?
Source: International Congress 2016 – Molecular footprints in lung cancer diagnosis and management
Year: 2016
Intersections of lung progenitor cells, lung disease and lung cancer
Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017
Year: 2017
Exploration of the evidence of cancer stem cells in lung cancer
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009
Nonsmall cell lung cancer
Source: Annual Congress 2012 - Maurizio Vignola Award for Innovation in Pneumology Ceremony (supported by Chiesi Foundation) followed by Clinical Year in Review I
Year: 2012
Circulating CD133(+) stem cells in lung cancer patients
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011
Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Non-small cell lung cancer in never-smokers
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Modulation of tumor-microenvironmental factors and cancer growth in co-cultures of fresh human lung tissue and patient-derived cancer cells
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
The influence of erythropoietin on growth and survival in non-small cell lung cancer cell lines
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Stem cells for lung vascular repair
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
Stem cell strategies to heal/replace damaged lung tissue
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004
Small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Bone marrow-derived mesenchymal stem cells involve in lymphangiogenesis of lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
CD33
+
CD14
-
CD11b
+
CD66b
+
CD15
+
VEGFR-1
hi
myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014
Epithelial cell migration as a potential therapeutic target in early lung cancer
Source: Eur Respir Rev 2017; 26: 160069
Year: 2017
EpCAM-positive circulating cells in lung cancer patients
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept